TipRanks
Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market
DYN
Dyne Therapeutics
RESEARCH TOOLSreports
Want to see DYN full AI Analyst Report?

Dyne Therapeutics (DYN) Stock News & Sentiment

488 Followers
Dyne Therapeutics: Buy Rating Backed by Late-Stage Muscle Disease Platform, Multibillion-Dollar Opportunities, and Dual-Path Approval Strategy
Premium
Ratings
Dyne Therapeutics: Buy Rating Backed by Late-Stage Muscle Disease Platform, Multibillion-Dollar Opportunities, and Dual-Path Approval Strategy
20d ago
DYN
Dyne Maintained at Buy as Analyst Reaffirms $50 Price Target on Favorable DM1 Risk‑Reward Outlook
Premium
Ratings
Dyne Maintained at Buy as Analyst Reaffirms $50 Price Target on Favorable DM1 Risk‑Reward Outlook
1M ago
DYN
Dyne Therapeutics: Buy Rating Reiterated as FORCE Platform Expands; $47 Price Target Maintained
Premium
Ratings
Dyne Therapeutics: Buy Rating Reiterated as FORCE Platform Expands; $47 Price Target Maintained
2M ago
DYN
Dyne Therapeutics Upsized Equity Offering Strengthens Cash Runway
Premium
Company Announcements
Dyne Therapeutics Upsized Equity Offering Strengthens Cash Runway
2M ago
8K
DYN
Dyne Therapeutics Advances DYNE-251 With FDA Priority Review
Premium
Company Announcements
Dyne Therapeutics Advances DYNE-251 With FDA Priority Review
2M ago
8K
DYN
Joseph Thome Initiates Buy on Dyne Therapeutics, Citing Late-Stage Pipeline Strength and Multi-Billion-Dollar Peak Sales Potential
Premium
Ratings
Joseph Thome Initiates Buy on Dyne Therapeutics, Citing Late-Stage Pipeline Strength and Multi-Billion-Dollar Peak Sales Potential
3M ago
DYN
Dyne Therapeutics Names Barry Greene Independent Board Director
Premium
Company Announcements
Dyne Therapeutics Names Barry Greene Independent Board Director
3M ago
8K
DYN
More DYN News >

DYN News on the Web

Dyne Therapeutics Tumbles As RNA Therapy Hopes Dim
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Dyne Therapeutics Tumbles As Hot-Streak Rally Cools
TipRanks News
Neutral
Dyne Therapeutics, Inc. at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)
TipRanks News
Neutral
Dyne Therapeutics price target lowered to $26 from $30 at Baird
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Dyne Therapeutics (DYN), NewAmsterdam Pharma Company (NAMS) and Ionis Pharmaceuticals (IONS)
TipRanks News
Bullish
Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH
rttnews
Bullish

News Score - Last 7 Days

Neutral
DYN
Sector Average
Media Buzz
This Week3 articles
Weekly Average6.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DYN’s Media Buzz Sentiment?
3 articles about DYN were published this week. In an average week, 6.25 articles are published.
    What is DYN’s weekly average amount of articles?
    In an average week, 6.25 articles about DYN are published.
      What is DYN’s News Sentiment?
      100% of articles about DYN were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        LGNDLigand Pharma
        ABBVAbbVie
        ANABAnaptysBio
        CDNACareDx
        ARCTArcturus Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week